Department of Auricular Reconstruction, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
J Craniofac Surg. 2021 Oct 1;32(7):2301-2304. doi: 10.1097/SCS.0000000000007660.
Congenital microtia is a severe physiological defect and is among the most common craniofacial defects. It is characterized by severe auricle dysplasia, external auditory canal atresia or stenosis, and middle ear malformation, though inner ear development is mostly normal with some hearing occurring through bone conduction. Auricular reconstruction is the only treatment for congenital microtia. In this study, the authors integrated messenger ribonucleic acid and mass spectrometry data of cartilage obtained from the affected and unaffected sides of 16 unilateral microtia patients who had undergone ear reconstruction surgery. The authors next performed functional analyses to investigate differences in the proteome of the affected and unaffected ears to elicit molecular pathways involved in microtia pathogenesis. The authors collected 16 pairs samples. Proteomic and transcriptomic analyses identified 47 genes that were differentially expressed in affected and unaffected cartilage. Integrated pathway analysis implicated the involvement of genes related to cell adhesion, extracellular matrix organization, and cell migration in disease progression. Through the integration of gene and protein expression data in human primary chondrocytes, the authors identified molecular markers of microtia progression that were replicated across independent datasets and that have translational potential.
先天性小耳畸形是一种严重的生理缺陷,是最常见的颅面畸形之一。其特征为严重的耳廓发育不良,外耳道闭锁或狭窄,中耳畸形,但内耳发育基本正常,部分通过骨导产生听力。耳廓重建是先天性小耳畸形的唯一治疗方法。本研究中,作者整合了 16 例单侧小耳畸形患者接受耳部重建手术后病变侧和非病变侧软骨的信使核糖核酸和质谱数据。作者随后进行了功能分析,以研究病变耳和非病变耳蛋白质组的差异,以阐明小耳畸形发病机制中涉及的分子途径。作者收集了 16 对样本。蛋白质组学和转录组学分析鉴定出在病变和非病变软骨中差异表达的 47 个基因。综合通路分析提示与细胞黏附、细胞外基质组织和细胞迁移相关的基因参与疾病进展。通过整合人原代软骨细胞中的基因和蛋白质表达数据,作者鉴定了小耳畸形进展的分子标志物,这些标志物在独立数据集得到了复制,具有转化潜力。